CME Group Inc. (CME) stock
CMENasdaqSecurity & Commodity Brokers, Dealers, Exchanges & ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/3021% above fair value
$317.97+2.47 (+0.78%)
Close on Nov 13, 2026Market cap $113.81BP/E 26.1Yield 1.57%
CME EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
CME's EPS for the twelve months ending Sep 30, 2026 was $12.19, up 18.1% year over year. For fiscal 2025 it was $11.16, up 15.4% from the year before. Over ten years it grew 11.7% a year on average. The highest annual figure on record is $11.94 in fiscal 2017.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.16 | +15.4% |
| FY2024 | Dec 31, 2024 | $9.67 | +9.1% |
| FY2023 | Dec 31, 2023 | $8.86 | +19.7% |
| FY2022 | Dec 31, 2022 | $7.40 | +1.5% |
| FY2021 | Dec 31, 2021 | $7.29 | +24.2% |
| FY2020 | Dec 31, 2020 | $5.87 | -0.7% |
| FY2019 | Dec 31, 2019 | $5.91 | +3.5% |
| FY2018 | Dec 31, 2018 | $5.71 | -52.2% |
| FY2017 | Dec 31, 2017 | $11.94 | +163.6% |
| FY2016 | Dec 31, 2016 | $4.53 | +22.8% |
| FY2015 | Dec 31, 2015 | $3.69 | +10.1% |
| FY2014 | Dec 31, 2014 | $3.35 | +14.7% |
| FY2013 | Dec 31, 2013 | $2.92 | +8.1% |
| FY2012 | Dec 31, 2012 | $2.70 | -50.3% |
| FY2011 | Dec 31, 2011 | $5.43 | +89.9% |
| FY2010 | Dec 31, 2010 | $2.86 | +15.2% |
| FY2009 | Dec 31, 2009 | $2.48 | +2.3% |
| FY2008 | Dec 31, 2008 | $2.43 | -18.8% |
| FY2007 | Dec 31, 2007 | $2.99 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.89 | +16.1% |
| Q2 FY2026 | Jun 30, 2026 | $2.88 | +2.5% |
| Q1 FY2026 | Mar 31, 2026 | $3.18 | +21.4% |
| Q4 FY2025 | Dec 31, 2025 | $3.24 | +35.0% |
| Q3 FY2025 | Sep 30, 2025 | $2.49 | -0.4% |
| Q2 FY2025 | Jun 30, 2025 | $2.81 | +16.1% |
| Q1 FY2025 | Mar 31, 2025 | $2.62 | +11.5% |
| Q4 FY2024 | Dec 31, 2024 | $2.40 | +7.1% |
| Q3 FY2024 | Sep 30, 2024 | $2.50 | +21.4% |
| Q2 FY2024 | Jun 30, 2024 | $2.42 | +13.1% |
| Q1 FY2024 | Mar 31, 2024 | $2.35 | -3.3% |
| Q4 FY2023 | Dec 31, 2023 | $2.24 | +28.0% |
| Q3 FY2023 | Sep 30, 2023 | $2.06 | +10.2% |
| Q2 FY2023 | Jun 30, 2023 | $2.14 | +17.6% |
| Q1 FY2023 | Mar 31, 2023 | $2.43 | +24.6% |
| Q4 FY2022 | Dec 31, 2022 | $1.75 | +3.6% |
| Q3 FY2022 | Sep 30, 2022 | $1.87 | -27.5% |
| Q2 FY2022 | Jun 30, 2022 | $1.82 | +28.2% |
| Q1 FY2022 | Mar 31, 2022 | $1.95 | +21.9% |
| Q4 FY2021 | Dec 31, 2021 | $1.69 | +43.2% |
| Q3 FY2021 | Sep 30, 2021 | $2.58 | +124.3% |
| Q2 FY2021 | Jun 30, 2021 | $1.42 | +1.4% |
| Q1 FY2021 | Mar 31, 2021 | $1.60 | -25.2% |
| Q4 FY2020 | Dec 31, 2020 | $1.18 | -9.9% |
| Q3 FY2020 | Sep 30, 2020 | $1.15 | -35.4% |
| Q2 FY2020 | Jun 30, 2020 | $1.40 | -2.1% |
| Q1 FY2020 | Mar 31, 2020 | $2.14 | +54.0% |
| Q4 FY2019 | Dec 31, 2019 | $1.31 | +20.2% |
| Q3 FY2019 | Sep 30, 2019 | $1.78 | +47.1% |
| Q2 FY2019 | Jun 30, 2019 | $1.43 | -13.9% |
| Q1 FY2019 | Mar 31, 2019 | $1.39 | -21.0% |
| Q4 FY2018 | Dec 31, 2018 | $1.09 | -87.4% |
| Q3 FY2018 | Sep 30, 2018 | $1.21 | +33.0% |
| Q2 FY2018 | Jun 30, 2018 | $1.66 | +36.1% |
| Q1 FY2018 | Mar 31, 2018 | $1.76 | +49.2% |
| Q4 FY2017 | Dec 31, 2017 | $8.63 | +684.5% |
| Q3 FY2017 | Sep 30, 2017 | $0.91 | – |
| Q2 FY2017 | Jun 30, 2017 | $1.22 | – |
| Q1 FY2017 | Mar 31, 2017 | $1.18 | – |
| Q4 FY2016 | Dec 31, 2016 | $1.10 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?